[go: up one dir, main page]

NO20031902L - Farmasoytiske sammensetninger mot hodepine, migrene, kvalme og brekninger - Google Patents

Farmasoytiske sammensetninger mot hodepine, migrene, kvalme og brekninger

Info

Publication number
NO20031902L
NO20031902L NO20031902A NO20031902A NO20031902L NO 20031902 L NO20031902 L NO 20031902L NO 20031902 A NO20031902 A NO 20031902A NO 20031902 A NO20031902 A NO 20031902A NO 20031902 L NO20031902 L NO 20031902L
Authority
NO
Norway
Prior art keywords
nausea
vomiting
migraine
headache
pharmaceutical compositions
Prior art date
Application number
NO20031902A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031902D0 (no
Inventor
Raphael Barkan
Alexander Mirimsky
Original Assignee
Meditor Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL14463201A external-priority patent/IL144632A0/xx
Application filed by Meditor Pharmaceuticals Ltd filed Critical Meditor Pharmaceuticals Ltd
Publication of NO20031902D0 publication Critical patent/NO20031902D0/no
Publication of NO20031902L publication Critical patent/NO20031902L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20031902A 2000-09-05 2003-04-28 Farmasoytiske sammensetninger mot hodepine, migrene, kvalme og brekninger NO20031902L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22981200P 2000-09-05 2000-09-05
IL14463201A IL144632A0 (en) 2001-07-30 2001-07-30 Method and pharmaceutical compositions for treating headache, nausea and migraine
PCT/IL2001/000817 WO2002019961A2 (fr) 2000-09-05 2001-08-30 Compositions pharmaceutiques contre les cephalees, la migraine, les nausees et les vomissements

Publications (2)

Publication Number Publication Date
NO20031902D0 NO20031902D0 (no) 2003-04-28
NO20031902L true NO20031902L (no) 2003-06-09

Family

ID=26324036

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031902A NO20031902L (no) 2000-09-05 2003-04-28 Farmasoytiske sammensetninger mot hodepine, migrene, kvalme og brekninger

Country Status (21)

Country Link
US (2) US7148208B2 (fr)
EP (1) EP1315505B1 (fr)
JP (1) JP2004508311A (fr)
KR (1) KR100849999B1 (fr)
CN (1) CN100448439C (fr)
AT (1) ATE375797T1 (fr)
AU (2) AU2001286178B2 (fr)
BR (1) BR0113698A (fr)
CA (1) CA2420410C (fr)
CY (1) CY1107270T1 (fr)
DE (1) DE60131004T2 (fr)
DK (1) DK1315505T3 (fr)
ES (1) ES2296792T3 (fr)
HU (1) HUP0302362A3 (fr)
IL (1) IL154456A (fr)
MD (1) MD2447G2 (fr)
MX (1) MXPA03001737A (fr)
NO (1) NO20031902L (fr)
NZ (1) NZ524903A (fr)
PT (1) PT1315505E (fr)
WO (1) WO2002019961A2 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2447G2 (ro) * 2000-09-05 2005-12-31 Meditor Pharmaceuticals Ltd Compoziţie farmaceutică, utilizarea ei şi metodă de tratare a cefaleei, migrenei, greţurilor şi vomei
WO2007108004A2 (fr) * 2006-03-23 2007-09-27 Meditor Pharmaceuticals Ltd. Derives du s-alkylisothiouronium pour le traitement de maladies inflammatoires
EP2167050A1 (fr) * 2007-06-13 2010-03-31 Meditor Pharmaceuticals Ltd. Compositions pharmaceutiques à goût masqué de dérivés de s-alkylisothiuronium
RU2342923C1 (ru) * 2007-07-26 2009-01-10 Общество с ограниченной ответственностью "Бентус лаборатории" Дезинфицирующее антисептическое средство для обработки рук с увлажняющим эффектом (варианты)
US12011423B2 (en) 2007-11-06 2024-06-18 Foraviset Ltd. S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
EA030035B1 (ru) * 2007-11-06 2018-06-29 Меламед, Лемуил Применение s-этилизотиоурония диэтилфосфата для изготовления лекарственного средства для лечения нарушения матки
MD3619G2 (ro) * 2007-11-06 2009-01-31 Рафаэль Баркан Remediu medicamentos nazal cu acţiune anticongestivă
US8682687B2 (en) 2008-04-24 2014-03-25 The Invention Science Fund I, Llc Methods and systems for presenting a combination treatment
US9064036B2 (en) 2008-04-24 2015-06-23 The Invention Science Fund I, Llc Methods and systems for monitoring bioactive agent use
US8606592B2 (en) 2008-04-24 2013-12-10 The Invention Science Fund I, Llc Methods and systems for monitoring bioactive agent use
US20090270687A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for modifying bioactive agent use
US20100130811A1 (en) * 2008-04-24 2010-05-27 Searete Llc Computational system and method for memory modification
US9282927B2 (en) 2008-04-24 2016-03-15 Invention Science Fund I, Llc Methods and systems for modifying bioactive agent use
US9239906B2 (en) 2008-04-24 2016-01-19 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US20100063368A1 (en) * 2008-04-24 2010-03-11 Searete Llc, A Limited Liability Corporation Computational system and method for memory modification
US9026369B2 (en) 2008-04-24 2015-05-05 The Invention Science Fund I, Llc Methods and systems for presenting a combination treatment
US9662391B2 (en) 2008-04-24 2017-05-30 The Invention Science Fund I Llc Side effect ameliorating combination therapeutic products and systems
US20100069724A1 (en) * 2008-04-24 2010-03-18 Searete Llc Computational system and method for memory modification
US8930208B2 (en) 2008-04-24 2015-01-06 The Invention Science Fund I, Llc Methods and systems for detecting a bioactive agent effect
US9649469B2 (en) 2008-04-24 2017-05-16 The Invention Science Fund I Llc Methods and systems for presenting a combination treatment
US9560967B2 (en) 2008-04-24 2017-02-07 The Invention Science Fund I Llc Systems and apparatus for measuring a bioactive agent effect
US9449150B2 (en) 2008-04-24 2016-09-20 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US8615407B2 (en) 2008-04-24 2013-12-24 The Invention Science Fund I, Llc Methods and systems for detecting a bioactive agent effect
US8876688B2 (en) 2008-04-24 2014-11-04 The Invention Science Fund I, Llc Combination treatment modification methods and systems
US7974787B2 (en) * 2008-04-24 2011-07-05 The Invention Science Fund I, Llc Combination treatment alteration methods and systems
US8357117B2 (en) * 2008-08-06 2013-01-22 Family Health International Device and method for delivering an agent into breast milk while breastfeeding
WO2012018341A1 (fr) * 2010-08-05 2012-02-09 Family Health International Dispositif et procédé de délivrance d'un agent dans le lait maternel pendant l'allaitement
CN109523244B (zh) * 2018-11-02 2023-06-27 创新先进技术有限公司 一种基于母子账户的用于转移款项数据的方法和系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2419675A1 (fr) * 1978-03-16 1979-10-12 Philagro Sa Compositions fongicides a base de phosphites d'isothiouronium
GB9418912D0 (en) * 1994-09-20 1994-11-09 Fisons Corp Pharmaceutically active compounds
MD263C2 (ro) * 1995-03-01 1995-12-31 Виктор ГИКАВЫЙ Remediu cu acţiune antihipotensivă "IZOTURON"
MD586C2 (ro) * 1995-05-25 1997-03-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Substanţă medicamentoasă cu acţiune antihipotensivă "Difetur"
FR2753098B1 (fr) * 1996-09-06 1998-11-27 Sod Conseils Rech Applic Composition pharmaceutique comprenant au moins un inhibiteur de no synthase et au moins un piegeur des formes reactives de l'oxygene
ATE222758T1 (de) * 1996-09-26 2002-09-15 Meditor Pharmaceuticals Ltd S-alkylisothiouronium-derivate enthaltende pharmazeutische zusammensetzungen
EP1829539A3 (fr) * 1996-11-05 2008-02-20 HEADEXPLORER ApS Procédé de traitement de cephalees du type par tension nerveuse
MD1138C2 (ro) * 1997-02-17 1999-07-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Izopropilfosfit-S-izopropilizotiuroniu- substanţă cu acţiune hipertensivă
MD1223C2 (ro) * 1997-07-15 2000-01-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Aplicarea dimetilfosfatului de S-metil-izo-tiouroniu în calitate de substanţă vasoconstrictoare şi preparat farmaceutic pe baza lui
US6127420A (en) * 1997-08-22 2000-10-03 The Medical College Of Wisconsin Research Foundation, Inc. L-N5 -(1-imino-3-alkenyl) ornithine and related compounds and use thereof
MD1431G2 (ro) * 1998-01-16 2001-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Remedii antihipotensive
US6093743A (en) * 1998-06-23 2000-07-25 Medinox Inc. Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
FR2788771B1 (fr) * 1999-01-22 2001-04-13 Pf Medicament Nouvelles 1,2-alcoyl-1-[1-[aryl (alcoyl) oxyalcoyl] piperidin-4-yl]-3-aryl isothiourees substituees, leur preparation et leur application en therapeutique
AU3511500A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions
EP1797869A3 (fr) * 1999-07-21 2008-07-23 Omeros Corporation Solutions et procédés pour l'inhibition d'inflammations douloureuses et de détériorations du cartilage
MD2447G2 (ro) * 2000-09-05 2005-12-31 Meditor Pharmaceuticals Ltd Compoziţie farmaceutică, utilizarea ei şi metodă de tratare a cefaleei, migrenei, greţurilor şi vomei

Also Published As

Publication number Publication date
MD2447G2 (ro) 2005-12-31
CA2420410C (fr) 2011-04-26
EP1315505A2 (fr) 2003-06-04
AU8617801A (en) 2002-03-22
ATE375797T1 (de) 2007-11-15
CN100448439C (zh) 2009-01-07
NZ524903A (en) 2004-11-26
DE60131004D1 (de) 2007-11-29
US20040006044A1 (en) 2004-01-08
NO20031902D0 (no) 2003-04-28
EP1315505B1 (fr) 2007-10-17
BR0113698A (pt) 2003-12-09
US7148208B2 (en) 2006-12-12
MD2447F2 (en) 2004-05-31
MXPA03001737A (es) 2004-09-10
US8673979B2 (en) 2014-03-18
PT1315505E (pt) 2008-01-28
IL154456A (en) 2013-05-30
AU2001286178B2 (en) 2006-09-14
CN1464788A (zh) 2003-12-31
CA2420410A1 (fr) 2002-03-14
DE60131004T2 (de) 2008-07-31
DK1315505T3 (da) 2008-03-03
JP2004508311A (ja) 2004-03-18
KR20030055257A (ko) 2003-07-02
EP1315505A4 (fr) 2006-02-22
MD20020139A (en) 2002-11-30
HK1058009A1 (zh) 2004-04-30
ES2296792T3 (es) 2008-05-01
KR100849999B1 (ko) 2008-08-01
HUP0302362A2 (hu) 2003-11-28
WO2002019961A2 (fr) 2002-03-14
WO2002019961A3 (fr) 2002-08-15
CY1107270T1 (el) 2012-11-21
HUP0302362A3 (en) 2005-05-30
US20070088005A1 (en) 2007-04-19

Similar Documents

Publication Publication Date Title
NO20031902L (no) Farmasoytiske sammensetninger mot hodepine, migrene, kvalme og brekninger
TW200503708A (en) Gyrase inhibitors and uses thereof
ZA200701629B (en) Gyrase inhibitors and uses thereof
WO2022256586A3 (fr) Composés d&#39;indole substitués et leurs procédés d&#39;utilisation
MX2009009948A (es) Derivados de piridazinona utiles como inhibidores de glucano sintasa.
NO20050099L (no) 2-ureido-6-heteroaryl-3H-benzoimidazol-4-karboksylsyrederivater og relaterte forbindelser sa som gyrase- og/eller topoisomerase IV-inhibitorer for behandling av bakterielle infeksjoner
WO2006124698A3 (fr) Traitement au dronabinol de nausees et vomissements induits par chimiotherapie differee
NO20075099L (no) Alkynyl-pyrrolopyrmidiner og relaterte analoger som HSP90-inhibitorer
MX349137B (es) Metodos y composiciones para el tratamiento de infecciones persistentes y cancer por inhibicion de la ruta de muerte celular programada (pd-1).
TW200509924A (en) Compositions of cyclooxygenase-2 selective inhibitors and 5-HT 1B/1D agonists for the treatment and prevention of migraine
MX2012002994A (es) Lactamas heterociclo-substituidas farmaceuticamente utiles.
WO2002096361A3 (fr) Derives de 5-aralkylsulfonyl-3-(pyrrol-2-ylmethylidene)-2-indolinone utilises comme inhibiteurs de kinase
MY163477A (en) Pyrimidinyl-pyridazinone derivatives
TW200740470A (en) Diclofenac formulations and methods of use
MY144036A (en) Liquid pharmaceutical formulations of polonosetron
MX2012003316A (es) Compuestos triciclicos y usos farmaceuticos de los mismos.
TNSN08451A1 (en) Composition comprising at least one higher aliphatic alcohol and an extract of griffonia simplicifolia
WO2004112825A3 (fr) Combinaisons d&#39;antigenes associes a des tumeurs dans des compositions pour divers types de cancers
MY128061A (en) A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
WO2007110047A3 (fr) Terguride/proterguride pour le traitement de douleurs chroniques
MXPA05007339A (es) Derivados de alfa-aminoamida utiles como agentes antimigranosos.
RS27803A (en) Benzopyran derivatives substituted with secondary amines including tetrazole, method for preparation thereof and pharmaceutical compositions containing them
NO20024684D0 (no) Legemiddelkombinasjon for behandling av hodepine, omfattende et ikke-steroid anti-inflammatorisk legemiddel
WO2000074667A3 (fr) Methodes et compositions destinees a la modulation de l&#39;action de medicaments par deterioration de telomeres
MX2023011081A (es) Derivados de indolina como inhibidores de los receptores del dominio de discoidina (ddr).

Legal Events

Date Code Title Description
RE Reestablishment of rights (par. 72 patents act)
FC2A Withdrawal, rejection or dismissal of laid open patent application